These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7078419)

  • 1. Glycosylated hemoglobin and its temporal relationship to plasma glucose in non-insulin dependent (type 2) diabetes mellitus.
    Borsey DQ; Fraser DM; Gray RS; Elton RA; Smith AF; Clarke BF
    Metabolism; 1982 Apr; 31(4):362-5. PubMed ID: 7078419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of short-term changes in reversibly and irreversibly glycosylated haemoglobin AI: relevance to diabetes mellitus.
    Bolli G; Compagnucci P; Cartechini MG; De Feo P; Santeusanio F; Brunetti P
    Diabetologia; 1981 Jul; 21(1):70-2. PubMed ID: 7274615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. United Kingdom Prospective Diabetes Study (UKPDS). 13: Relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years.
    BMJ; 1995 Jan; 310(6972):83-8. PubMed ID: 7833731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation between hemoglobin AI and determinations of glucose in diabetics treated with and without insulin.
    Wålinder O; Wibell L; Tuvemo T
    Diabete Metab; 1980 Dec; 6(4):251-5. PubMed ID: 7009246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. U.K. prospective diabetes study. II. Reduction in HbA1c with basal insulin supplement, sulfonylurea, or biguanide therapy in maturity-onset diabetes. A multicenter study.
    Diabetes; 1985 Aug; 34(8):793-8. PubMed ID: 2862087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemoglobin AI in community care.
    Ahrén B; Bitzén PO; Scherstén B
    Acta Med Scand Suppl; 1981; 656():63-7. PubMed ID: 6953752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical value of HbAI-determinations.
    Wålinder O; Wibell L; Boström H
    Acta Med Scand Suppl; 1980; 639():17-22. PubMed ID: 6932809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.
    Lancet; 1998 Sep; 352(9131):854-65. PubMed ID: 9742977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of glycosylated haemoglobin concentration during artificial endocrine pancreas treatment of diabetics. Evidence for a short-term effect on HbA 1 (a+b+c) levels.
    Bolli G; Cartechini MG; Compagnucci P; Santeusanio F; Massi-Benedetti M; Calabrese G; Puxeddu A; Brunetti P
    Diabetologia; 1980; 18(2):125-30. PubMed ID: 6988271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.
    DeFronzo RA; Goodman AM
    N Engl J Med; 1995 Aug; 333(9):541-9. PubMed ID: 7623902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma insulin and glucose levels in maturity onset diabetics treated with chlorpropamide.
    Shenfield GM; Logan A; Shirling D; Baird J
    Diabetologia; 1977 Aug; 13(4):367-71. PubMed ID: 913926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycosylated haemoglobin concentrations in newly diagnosed diabetics before and during treatment.
    Fraser DM; Smith AF; Gray RS; Borsey DQ; Sinclair ME; Clarke BF; Duncan LJ
    Br Med J; 1979 Apr; 1(6169):979-81. PubMed ID: 435952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. United Kingdom Prospective Diabetes Study Group.
    Ann Intern Med; 1998 Feb; 128(3):165-75. PubMed ID: 9454524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial.
    Fonseca V; Rosenstock J; Patwardhan R; Salzman A
    JAMA; 2000 Apr; 283(13):1695-702. PubMed ID: 10755495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin for obese, insulin-treated diabetic patients: improvement in glycaemic control and reduction of metabolic risk factors.
    Giugliano D; Quatraro A; Consoli G; Minei A; Ceriello A; De Rosa N; D'Onofrio F
    Eur J Clin Pharmacol; 1993; 44(2):107-12. PubMed ID: 8453955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [HbAI as an indicator of blood glucose regulation in diabetic patients].
    Oimomi M; Ishikawa K; Kawasaki T; Kubota S; Takagi K; Tanke G; Yoshimura Y; Baba S
    Nihon Naika Gakkai Zasshi; 1983 Sep; 72(9):1159-62. PubMed ID: 6663185
    [No Abstract]   [Full Text] [Related]  

  • 18. High density lipoprotein cholesterol and apolipoprotein a-1 concentrations in non-insulin dependent diabetics treated by diet and chlorpropamide.
    Billingham MS; Leatherdale BA; Hall RA; Bailey CJ
    Diabete Metab; 1982 Sep; 8(3):229-33. PubMed ID: 6814965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison between the action of chlorpropamide and an association of chlorpropamide with metformin on the daily fluctuations of glucose and insulin in diabetics].
    Berger W; Goschke H; Denes A
    J Med Lyon; 1972 Feb; 53(222):168 passim. PubMed ID: 5046641
    [No Abstract]   [Full Text] [Related]  

  • 20. Selective determination of non-enzymatic glycosylated serum albumin as a medium term index of diabetic control.
    Wörner W; Pfleiderer S; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1993 May; 31(5):218-22. PubMed ID: 8314651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.